EFFECTS OF SIMVASTATIN AND ALPHA-TOCOPHEROL ON DISTURBED NERVE CONDUCTION IN OBESE SPRAGUE DAWLEY RATS
AbstractBackground: The incidence of obesity is increasing worldwide. The neuropathy associated withobesity, that is evident from disturbed nerve conduction, is one of the complications for which anumber of treatment options are being considered. In this study, Simvastatin, a hydroxyl methylglutaryl coenzyme A reductase inhibitor and alpha-tocopherol, a dietary antioxidant are comparedfor their effects on sciatic nerve conduction velocity. Objectives: To compare the effects ofSimvastatin and alpha-tocopherol on sciatic nerve conduction velocity in obese rats. Methods:The study was a Randomised control trial conducted from December 2008 to November 2009.One hundred and twenty adult male Sprague Dawley rats were divided into four groups with 30rats in each group. One group of rats was taken as control with normal diet while other threegroups were given high fat diet (HFD) for the whole study period. Along with the high fat diet,group III and group IV were given Simvastatin and alpha-tocopherol supplemented dietrespectively. At the end of study, conduction velocity of sciatic nerve was determined with thehelp of PowerLab® data acquisition system. Results: The three groups with HFD showed morethan 25% increase in weight at the end of study compared to control group. The control groupwith high fat diet (Group II) showed decreased sciatic nerve conduction velocity when comparedwith control (Group I). Both the groups that were given Simvastatin and alpha-tocopherol eachshowed improvement in sciatic nerve conduction velocity (p<0.001) after four weeks whencompared with the group that was given HFD without any supplementation. However with alphatocopherol, the nerve conduction velocity was improved more significantly. Conclusions:Simvastatin and alpha-tocopherol both are effective for improving sciatic nerve conductionvelocity in HFD induced obesity.Keywords: Obesity, Simvastatin, nerve conduction velocity, alpha-tocopherol, High Fat Diet
Eckersley ME, Losing the battle of the bulge: causes and
consequences of increasing obesity. Med J Aust 2001;174:590–
Shafi S, Rao MH, Soomro IB. The effect of life style and socioeconomic factors in the development of obesity in young adults.
Pak J Med Res 2004;43(2):65–9.
Knobler H, Malnick SDH. The medical complications of obesity.
Q J Med 2006;99:565–79.
Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K.
Involvement of sex, strain and age factors in high fat diet induced
obesity in C-57BL/6J and BALB/cA mice. Exp Anim
Ylitalo KR, Sowers M, Heeringa S. Peripheral neuropathy in
individuals with cardiometabolic clustering and obesity. Diabetes
Miscio G, Guastamacchia G, Brunani A, Priano L, Baudo S,
Mauro A. Obesity and peripheral neuropathy risk: a dangerous
liaison. J Peripher Nerv Syst 2005;10:354–8.
Hilton TN, Tuttle LJ, Bohnert KL. Mueller MJ, Sinacore DR.
Excessive adipose tissue infiltration in skeletal muscle in
individuals with obesity, diabetes mellitus and peripheral
neuropathy: Association with performance and function. Phys
Ziegler D, Sohr CGH, Nourooz-Zadeh J. Oxidative stress and
antioxidant defense in relation to the severity of diabetic
polyneuropathy and cardiovascular autonomic neuropathy.
Diabetic Care 2004;27:2178–83.
Low AP, Nickander KK, Tritschler HJ. The roles of oxidative
stress and antioxidant treatment in experimental diabetic
neuropathy. Diabetes 1997;46:38–42.
Stahl W, Sies H. Antioxidant defence: vitamin E and C and
carotenoids. Diabetes 1997;46:14–8.
Pace A, Giannarelli D, Galie E, Savarese A, Carano S, Della
GM, et al. Vitamin E neuroprotection for cisplatin neuropathy: a
randomized, placebo controlled trial. Neurology 2010;74:762–6.
Cameron NE. Metabolic and vascular factors in the pathogenesis
of diabetec neuropathy. Diabetes 1997;46:31–7.
Obrosova IG, Inytska O, Lysogubov VV, Pavlov IA, Mashtalir
N, Nadler JL, et al. High fat diet induced neuropathy of prediabetes and obesity. Effects of “healthy” diet and aldose
reductase inhibition. Diabetes 2007;56:2598–608.
Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H,
Patel S, et al. Simvastatin has anti-inflammatory and
antiatherosclerotic activities independent of plasma cholesterol
lowering. Arterioscler Thromb Vasc Biol 2001;21:115–21.
Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD,
Yorek MA. Progression of vascular and neural dysfunction in
sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J
Physiol Endocrinal Metab 2005;289:113–22.
Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB,
Caldwell RW. Simvastatin improves diabetes induced coronary
endothelial dysfunction. J Pharmacol Exp Tther 2006;319:386–
Levin BE, Dunn-Meynell AA. Defense of body weight depends
on dietary composition and palatability in rats with diet induced
obesity. Am J Physiol Regulatory Integrative Comp Physiol
Head KA. Peripheral neuropathy: Pathogenic mechanisms and
alternative therapies. Alternative Medicine Review
Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD,
Yorek MA. Effect of antioxidant treatment of streptozotocininduced diabetic rats on endoneurial blood flow, motor nerve
conduction velocity and vascular reactivity of epineurial
arterioles of the sciatic nerves. Diabetes 2001;50:1927–37.
Delbosc S, Cristol JP, Descomps B, Mimran A , Jover B.
Simvastatin prevents angiotensin II induced cardiac alterations
and oxidative stress. Hypertension 2002;40:142–7.
Tutunco NB, Bayraktar M, Varli K. Reversal of defective nerve
conduction with vitamin E supplementation in type 2 diabetes.
Diabetec Care 1998;21:1915–8.
Klivenyi P, Karg E, Rozsa C, Horvath R, Komoly S, Nemeth I, et
al. Alpha-tocopherol/ lipid ratio in blood is decreased in patients
with Leber’s hereditary optic neuropathy and asymptomatic
carriers of the 1178 mtDNA mutation. J Neurol Neurosurg
Khanna S, Roy S, Parinandi NL, Maurer M, Sen CK.
Characterization of the potent neuroprotective properties of the
natural vitamin E á-tocotrienol. J Neurochem 2006;98:1474–86.
Van Dam PS, Brvenboer B, Van Asbeck BS, Marx JJ, Gispen
WH. High rat food vitamin E content improves nerve function in
streptozotocin-diabetic rats. Eur J Pharmacol 1999;376:217–22.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.